FR2433527A1 - Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant - Google Patents

Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant

Info

Publication number
FR2433527A1
FR2433527A1 FR7919037A FR7919037A FR2433527A1 FR 2433527 A1 FR2433527 A1 FR 2433527A1 FR 7919037 A FR7919037 A FR 7919037A FR 7919037 A FR7919037 A FR 7919037A FR 2433527 A1 FR2433527 A1 FR 2433527A1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical composition
composition containing
pyrimidinone derivatives
novel pyrimidinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7919037A
Other languages
English (en)
French (fr)
Other versions
FR2433527B1 (de
Inventor
Barry John Price
John Watson Clitherow
John Bradshaw
Michael Martin-Smith
Duncan Bruce Judd
Roger Hayes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2433527A1 publication Critical patent/FR2433527A1/fr
Application granted granted Critical
Publication of FR2433527B1 publication Critical patent/FR2433527B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7919037A 1978-07-26 1979-07-24 Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant Granted FR2433527A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7831153 1978-07-26

Publications (2)

Publication Number Publication Date
FR2433527A1 true FR2433527A1 (fr) 1980-03-14
FR2433527B1 FR2433527B1 (de) 1982-10-15

Family

ID=10498669

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7919037A Granted FR2433527A1 (fr) 1978-07-26 1979-07-24 Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant

Country Status (14)

Country Link
US (1) US4524071A (de)
JP (1) JPS5540670A (de)
AU (1) AU534744B2 (de)
BE (1) BE877889A (de)
CH (1) CH642952A5 (de)
DE (1) DE2928842A1 (de)
DK (1) DK310779A (de)
ES (1) ES482869A1 (de)
FR (1) FR2433527A1 (de)
GB (1) GB2030979B (de)
IT (1) IT1117778B (de)
NL (1) NL7905775A (de)
SE (1) SE7906372L (de)
ZA (1) ZA793443B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536394A1 (fr) * 1982-11-18 1984-05-25 Montedison Spa Derives de pyrimidine-4-one dotes d'une activite herbicide
EP0140466A2 (de) * 1983-07-09 1985-05-08 Smith Kline & French Laboratories Limited Pyrimidinon-Derivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
EP0186275A2 (de) * 1984-12-28 1986-07-02 Yamanouchi Pharmaceutical Co., Ltd. 2-Substituierte Amino-4(1H)-pyrimidinonderivate, deren Herstellung und diese enthaltende medizinische Zusammensetzungen

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
US4607107A (en) * 1980-10-01 1986-08-19 Smith Kline & French Laboratories Ltd. (4-aminoalkyl-2-pyridyl alkyl)guanidines
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4620001A (en) * 1981-02-06 1986-10-28 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
JPS58110681A (ja) * 1981-12-23 1983-07-01 Showa Denko Kk 純鉄の錆取り方法
PT77623B (en) * 1982-11-25 1986-03-19 Smith Kline French Lab Process for the preparation of a small class of histamine h2-antagonists
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
JO1410B1 (en) * 1984-11-03 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Vehicles
JPH02101170A (ja) * 1988-10-07 1990-04-12 Mitsubishi Electric Corp アルミニウム合金表面の前処理方法
JPH04323392A (ja) * 1991-04-19 1992-11-12 Nkk Corp チタン材の酸洗処理方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
IN146736B (de) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536394A1 (fr) * 1982-11-18 1984-05-25 Montedison Spa Derives de pyrimidine-4-one dotes d'une activite herbicide
EP0140466A2 (de) * 1983-07-09 1985-05-08 Smith Kline & French Laboratories Limited Pyrimidinon-Derivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
EP0140466A3 (de) * 1983-07-09 1987-12-09 Smith Kline & French Laboratories Limited Pyrimidinon-Derivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
EP0186275A2 (de) * 1984-12-28 1986-07-02 Yamanouchi Pharmaceutical Co., Ltd. 2-Substituierte Amino-4(1H)-pyrimidinonderivate, deren Herstellung und diese enthaltende medizinische Zusammensetzungen
EP0186275A3 (de) * 1984-12-28 1987-05-20 Yamanouchi Pharmaceutical Co., Ltd. 2-Substituierte Amino-4(1H)-pyrimidinonderivate, deren Herstellung und diese enthaltende medizinische Zusammensetzungen

Also Published As

Publication number Publication date
SE7906372L (sv) 1980-01-28
DE2928842A1 (de) 1980-02-14
ES482869A1 (es) 1980-09-01
AU534744B2 (en) 1984-02-16
IT1117778B (it) 1986-02-24
NL7905775A (nl) 1980-01-29
DK310779A (da) 1980-02-29
ZA793443B (en) 1980-12-31
BE877889A (fr) 1979-11-16
GB2030979A (en) 1980-04-16
FR2433527B1 (de) 1982-10-15
AU4924979A (en) 1980-01-31
GB2030979B (en) 1983-03-02
CH642952A5 (de) 1984-05-15
IT7949849A0 (it) 1979-07-24
US4524071A (en) 1985-06-18
JPS5540670A (en) 1980-03-22

Similar Documents

Publication Publication Date Title
FR2433527A1 (fr) Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant
FR2377418A1 (fr) Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
FR2444031A1 (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2405946A1 (fr) Nouveaux derives de l'acide 3-methyl-crotonique et procede pour leur preparation
FR2445319A1 (fr) Derives de pyridine, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2434154A1 (fr) Nouveaux derives d'imidazole, utiles notamment comme anticonvulsivants, et leur procede de preparation
BE841309A (fr) Nouveaux ethers et thioethers de 1-aryl-2-(1-imidazoyl)alkyle, leur procede de preparation et composition pharmaceutique les contenant
FR2401925A1 (fr) Nouveaux derives de la mitomycine c utiles comme medicaments et procede de leur preparation
FR2430953A1 (fr) Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
FR2363559A1 (fr) Nouveaux derives de perhydro-aza-heterocycles utiles comme medicaments et procede pour leur preparation
FR2368471A1 (fr) Nouveaux amides d'acides omega-amino-carboxyliques et procedes pour leur preparation
FR2377419A1 (fr) Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2370744A1 (fr) Nouveaux derives d'aminopropanol, procede pour leur preparation et medicaments contenant ces composes
FR2362845A1 (fr) Nouveaux derives de o-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques les contenant
BE878230A (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2381048A1 (fr) Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2362841A1 (fr) Derives d'acides heterocyclyl-carboxyliques acyles utiles comme medicaments et procede pour leur preparation
BE904864A (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant.
FR2383941A1 (fr) Nouveaux derives pyrimidinyliques et leur procede de preparation
FR2419289A1 (fr) Derives de glyoxal-2-oxime et leur procede de preparation
FR2370727A1 (fr) Nouveaux derives substitues de o-phenylenediamine, leur procede de preparation et medicament les contenant
FR2355839A1 (fr) Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse